Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04850989 · ClinicalTrials.gov registry record · NA

Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia

A NA study of Social Anxiety Disorder, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT04850989 is a NA study of Social Anxiety Disorder that has completed, run by Penn State University. The registered enrollment target is 44 participants, below the 159-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04850989, a NA study of Social Anxiety Disorder, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the efficacy virtual reality videos to facilitate exposure therapy in social anxiety disorder (SAD). The exposure therapy videos are the focus of this experiment. Essentially, we are testing the efficacy of the Virtual Reality Exposure Therapy (VRET) scripts (i.e., virtual scenarios, people, and interactions that we expose socially anxious people to). To this end, the goal of the current study is to help people with social anxiety overcome their phobias. Individuals who experience a difficult time building social relationships, accomplishing everyday tasks, or pursuing job interviews can practice those same behaviors in a controlled environment. Specifically, we aim to test the following hypotheses: (1) Virtual reality exposure therapy intervention (vs. waitlist control condition) is effective for treating SAD symptoms. (2) Participants who received the VRET will experience maintenance of treatment gains following 3-month and 6-month post-termination of treatment. (3) Users of the virtual reality exposure therapy will demonstrate high amounts of acceptability of the treatment.

Conditions Studied

Interventions

  • DEVICE Pico Goblin VR headset

Study Locations (1)

Pennsylvania

  • The Pennsylvania State University - University Park

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2018-12-18
Est. Completion 2020-12-31
Phase NA

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT04850989

The ClinicalTrials.gov registry entry for NCT04850989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 159-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (72% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Social Anxiety Disorder appearing as the primary indexed condition, and to 1 intervention - of which Pico Goblin VR headset is the first listed.

NCT04850989 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04850989 about?

NCT04850989 is a clinical study titled "Efficacy of Virtual Reality Exposure Therapy Scripts for Social Phobia". The purpose of this study is to test the efficacy virtual reality videos to facilitate exposure therapy in social anxiety disorder (SAD). The exposure therapy videos are the focus of this experiment. Essentially, we are testing the efficacy of the Virtual Reality Exposure Therapy (VRET) scripts (i.e...

What is the current status of trial NCT04850989?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2018-12-18. Estimated completion is 2020-12-31.

What conditions does trial NCT04850989 study?

This clinical trial studies the following conditions: Social Anxiety Disorder.

What interventions are being tested in trial NCT04850989?

The interventions under investigation include: Pico Goblin VR headset (DEVICE).

Who is sponsoring clinical trial NCT04850989?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04850989 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.